Published: 2016-03-31

Articles

Myeloma and amyloid

Mini-review: highlights of cardio-oncology

Anna Blaes , Douglas Sawyer , Daniel Lenihan

5-7

PDF

Bone marrow transplantation – how can we maximize cardiac status?

Mini-review: highlights of cardio-oncology

Joseph R. Carver

8-10

PDF

Tyrosine kinase inhibitors in hematologic malignancy: should we be concerned?

Mini-review: highlights of cardio-oncology

Charles Porter

11-13

PDF

Cardiovascular concerns from radiation therapy and other radiation exposure

Mini-review: key problems in cardio-oncology

Hassan Tariq , Eric E. Harrison

14-17

PDF

Imaging for Cardiotoxicity: Many Issues, Many Questions

Mini-review: key problems in cardio-oncology

Sebastian Szmit

18-23

PDF

Cardio-oncology: What is the future?

Mini-review: future in cardio-oncology

Jeanne M. DeCara , Joerg Herrmann

24-26

PDF

Ongoing research developments in cardio-oncology

Mini-review: future in cardio-oncology

Susan Dent , Olexiy Aseyev , Daniel Lenihan

27-28

PDF

Opposite changes of regulatory T cell blood content may differentially contribute to atherosclerosis or lymphoproliferative disorders

Original article

Ekaterina Pylaeva , Aleksandra Potekhina , Olga Pogorelova , Maria Tripoten , Tatiana Balakhonov , Anastasia Filatova , Elena Klesareva , Olga Afanasieva , Elena Noeva , Tatiana Arefieva

29-36

PDF

The mTOR signalling pathways in the pathogenesis and treatment of neuroendocrine tumours

Review article

Agnieszka Kolasińska-Ćwikła

37-42

PDF